Immunocore Holdings PLC expected to post earnings of 1 cent a share - Earnings Preview
Immunocore Holdings PLC <IMCR.OQ> expected to post earnings of 1 cent a share - Earnings Preview
Immunocore Holdings PLC IMCR.OQ IMCR.O is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2026
The Abingdon Oxfordshire-based company is expected to report a 12.7% increase in revenue to $110.374 million from $97.96 million a year ago, according to the mean estimate from 12 analysts, based on LSEG data.
LSEG's mean analyst estimate for Immunocore Holdings PLC is for earnings of 1 cent per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Immunocore Holdings PLC is $73.00, about 125.1% above its last closing price of $32.43
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.24 | -0.26 | 0.25 | Beat | 196.4 |
Dec. 31 2026 | -0.16 | -0.24 | -0.60 | Missed | -146.7 |
Sep. 30 2025 | -0.23 | -0.26 | 0.00 | Beat | 100 |
Jun. 30 2025 | -0.17 | -0.20 | -0.20 | Met | -1.7 |
Mar. 31 2025 | -0.37 | -0.39 | 0.10 | Beat | 125.7 |
Dec. 31 2024 | -0.29 | -0.26 | -0.47 | Missed | -83 |
Sep. 30 2024 | -0.35 | -0.35 | 0.17 | Beat | 148.4 |
Jun. 30 2024 | -0.55 | -0.48 | -0.23 | Beat | 51.7 |
This summary was machine generated August 4 at 08:41 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)